Renalytix plc - Sponsored ADR (RNLXY) vs Zhongchao Inc. (ZCMD)
Renalytix plc - Sponsored ADR and Zhongchao Inc. are both Health Information Services companies. Renalytix plc - Sponsored ADR is the larger, with a market value of $17.2M against $8.8M — 2.0× the size. Zhongchao Inc. grew revenue faster over the last twelve months: −6.64% against −18.3%. Zhongchao Inc. has the higher net margin (−26.2% vs −1,695.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Zhongchao Inc. leads on 8 and Renalytix plc - Sponsored ADR on 3.
Valuation
Profitability
| Metric | RNLXY | ZCMD | Health Information Services median |
|---|---|---|---|
| Gross margin | 14.52% | 45.49% | 63.38% |
| Operating margin | (1,087.73%) | 0.00% | (8.35%) |
| Net margin | (1,695.90%) | (26.16%) | (14.70%) |
| Free cash flow margin | 0.00% | 0.00% | 0.58% |
| Return on equity | 0.00% | 0.00% | (6.82%) |
| Return on assets | 0.00% | 0.00% | (6.02%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack